Protalix BioTherapeutics (PLX) Institutional Ownership → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free PLX Stock Alerts $1.15 -0.03 (-2.54%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)CurrentInstitutional OwnershipPercentage16.53%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$488.12KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$27.59K Get PLX Insider Trade Alerts Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PLX Institutional Buying and Selling by Quarter Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Protalix BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/2/2024Bailard Inc.68,100$121K0.0%N/A0.095% 1/19/2024 Denali Advisors LLC94,700$169K0.1%-14.1%0.132% 11/15/2023GSA Capital Partners LLP496,781$825K0.1%N/A0.694% 11/13/2023Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234% 11/7/2023Barclays PLC46,511$77K0.0%+251.6%0.065% 10/27/2023 Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193% Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/24/2023Bank of New York Mellon Corp165,680$275K0.0%+12.8%0.231% 10/13/2023SG Americas Securities LLC30,008$50K0.0%N/A0.042% 9/21/2023Barclays PLC13,230$26K0.0%+561.5%0.018% 8/11/2023Natixis132,000$264K0.0%N/A0.202% 8/4/2023American International Group Inc.27,034$54K0.0%N/A0.041% 7/31/2023Orin Green Financial LLC60,150$120K0.1%N/A0.092% 7/18/2023 Denali Advisors LLC110,200$220K0.1%N/A0.168% 5/10/2023Connor Clark & Lunn Investment Management Ltd.158,703$333K0.0%N/A0.243% 5/9/2023Aptus Capital Advisors LLC16,010$34K0.0%N/A0.024% 2/7/2023Commonwealth Equity Services LLC50,100$68K0.0%N/A0.101% 7/26/2022Capital Performance Advisors LLP25,974$28K0.0%N/A0.055% 5/9/2022Meitav Dash Investments Ltd.244,332$257K0.0%N/A0.527% 4/18/2022 Spire Wealth Management148,800$158K0.0%+18.3%0.321% 1/31/2022Commonwealth Equity Services LLC40,290$33K0.0%N/A0.088% 1/14/2022 Spire Wealth Management125,800$113K0.0%+598.9%0.276% 11/15/2021GSA Capital Partners LLP254,871$339K0.0%N/A0.559% 11/12/2021Credit Suisse AG31,974$43K0.0%-51.5%0.070% 8/18/2021Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 8/17/2021Walleye Capital LLC346,539$662K0.0%N/A0.764% 8/17/2021Walleye Trading LLC135,000$258K0.0%N/A0.297% 8/17/2021Bridgeway Capital Management LLC393,890$752K0.0%+30.2%0.868% 8/16/2021Morgan Stanley1,861,819$3.56M0.0%+3,723,538.0%4.102% 8/16/2021Credit Suisse AG65,925$126K0.0%+559.3%0.145% 8/13/2021Renaissance Technologies LLC30,075$57K0.0%-94.1%0.066% 8/12/2021XTX Topco Ltd17,148$33K0.0%N/A0.038% 8/11/2021Susquehanna Fundamental Investments LLC66,100$126K0.0%N/A0.146% 8/5/2021Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 5/19/2021Virtu Financial LLC27,744$124K0.0%N/A0.061% 5/18/2021Psagot Investment House Ltd.3,095,741$13.81M0.3%+558.3%6.821% 5/17/2021Schonfeld Strategic Advisors LLC89,278$399K0.0%N/A0.197% 5/17/2021DAFNA Capital Management LLC1,204,825$5.37M1.3%N/A2.655% 5/14/2021Laurion Capital Management LP42,813$191K0.0%N/A0.094% 5/14/2021Credit Suisse AG10,000$45K0.0%N/A0.022% 5/13/2021Renaissance Technologies LLC507,634$2.26M0.0%+3.9%1.119% Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.5/10/2021Phoenix Holdings Ltd.244,113$1.09M0.0%N/A0.538% 5/7/2021D.A. Davidson & CO.130,700$583K0.0%N/A0.288% 4/30/2021Ground Swell Capital LLC14,684$65K0.2%N/A0.032% 4/28/2021DAVENPORT & Co LLC12,000$54K0.0%N/A0.026% 2/17/2021Jane Street Group LLC22,218$81K0.0%+51.5%0.067% 2/16/2021Squarepoint Ops LLC22,068$80K0.0%-50.6%0.066% 2/4/2021GSA Capital Partners LLP10,042$36K0.0%N/A0.030% 11/17/2020Jane Street Group LLC14,661$57K0.0%-89.8%0.044% 11/16/2020Squarepoint Ops LLC44,679$173K0.0%N/A0.134% 11/12/2020Arrowstreet Capital Limited Partnership45,853$177K0.0%+32.3%0.138% 11/10/2020Phoenix Holdings Ltd.204,355$751K0.0%+8.5%0.613% 8/31/2020Bridgeway Capital Management Inc.174,291$661K0.0%+94.8%0.537% 8/17/2020Jane Street Group LLC143,821$542K0.0%+185.6%0.443% 8/12/2020Bank of Montreal Can173,704$615K0.0%N/A0.535% 8/10/2020Phoenix Holdings Ltd.188,336$681K0.0%N/A0.581% 7/29/2020Psagot Investment House Ltd.470,255$1.73M0.0%+15.7%1.450% 5/15/2020Jane Street Group LLC50,352$124K0.0%+53.4%0.339% (Data available from 1/1/2016 forward) PLX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PLX shares? During the previous two years, 15 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were GSA Capital Partners LLP ($825K), Connor Clark & Lunn Investment Management Ltd. ($278K), Bank of New York Mellon Corp ($275K), Natixis ($264K), Meitav Dash Investments Ltd. ($257K), Allspring Global Investments Holdings LLC ($229K), and Denali Advisors LLC ($169K).Learn more on PLX's institutional investors. What percentage of Protalix BioTherapeutics stock is owned by institutional investors? 16.53% of Protalix BioTherapeutics stock is owned by institutional investors. Learn more on PLX's institutional investor holdings. Which institutional investors have been buying Protalix BioTherapeutics stock? Of the 15 institutional investors that purchased Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: GSA Capital Partners LLP ($496.78K), Meitav Dash Investments Ltd. ($244.33K), Connor Clark & Lunn Investment Management Ltd. ($210.70K), Allspring Global Investments Holdings LLC ($137.91K), Natixis ($132K), Denali Advisors LLC ($110.20K), and Bailard Inc. ($68.10K). How much institutional buying is happening at Protalix BioTherapeutics? Institutional investors have bought a total of 1,672,566 shares in the last 24 months. This purchase volume represents approximately $1.13M in transactions. Which Protalix BioTherapeutics major shareholders have been selling company stock? The following institutional investors have sold Protalix BioTherapeutics stock in the last 24 months: Denali Advisors LLC ($15.50K). How much institutional selling is happening at Protalix BioTherapeutics? Institutional investors have sold a total of 15,500 shares in the last 24 months. This volume of shares sold represents approximately $27.59K in transactions. Related Companies: AlloVir Major Shareholders Curis Major Shareholders Atara Biotherapeutics Major Shareholders Gritstone bio Major Shareholders CEL-SCI Major Shareholders Cognition Therapeutics Major Shareholders Athira Pharma Major Shareholders Passage Bio Major Shareholders bluebird bio Major Shareholders Vigil Neuroscience Major Shareholders This page (NYSE:PLX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.